Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
- PMID: 1554664
- DOI: 10.1111/j.1471-0528.1992.tb14470.x
Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin
Abstract
Objective: To assess the effect of moderate obesity on the outcome of induction of ovulation with low dose gonadotrophin in women with polycystic ovary syndrome (PCOS).
Design: Retrospective analysis of women with PCOS treated consecutively. An analysis of the impact of obesity on outcome of pregnancy using data from the North West Thames Regional (NWTR) obstetric database was included for comparison.
Setting: Induction of ovulation clinic at the Samaritan Hospital for Women (St. Mary's Hospital Group).
Subjects: 100 women with clomiphene-resistant anovulation associated with PCOS. 75 were of normal weight (BMI 19-24.9 kg/m2, lean group) and 25 were moderately overweight (BMI 25-27.9 kg/m2, obese group).
Interventions: Induction of ovulation using low doses of gonadotrophins with small, stepwise increments in dosage as required.
Main outcome measures: Rates of ovulation, pregnancy and miscarriage; daily and total doses of gonadotrophin required for induction of ovulation.
Results: The proportion of ovulatory cycles was significantly greater in the lean group (77%) compared with the obese group (57%) (chi 2 9.8, P less than 0.001). Obese women required larger doses of gonadotrophin to achieve ovulation (P less than 0.001). The proportion of women who achieved at least one pregnancy was similar in the two groups (39% vs 48%) but miscarriage was more frequent in the obese group (60% vs 27%; P less than 0.05). This difference was independent of the baseline and/or mid-follicular luteinizing hormone (LH) concentration either before or during treatment. Analysis of data from the North West Thames Health Region obstetric database confirmed an increased risk of miscarriage in moderately obese women which was independent of maternal age.
Conclusions: Moderate obesity in women with PCOS, treated with low dose gonadotrophin, is associated with an increased risk of miscarriage. This is reflected in the results of analysis of the effect of obesity on outcome of pregnancy in the general population. It is therefore important to encourage weight reduction in obese women with PCOS before considering therapy to induce ovulation.
Similar articles
-
Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome.Hum Reprod. 1991 Sep;6(8):1095-9. doi: 10.1093/oxfordjournals.humrep.a137491. Hum Reprod. 1991. PMID: 1806568
-
Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.J Obstet Gynaecol. 2021 Nov;41(8):1234-1239. doi: 10.1080/01443615.2020.1849069. Epub 2021 Feb 24. J Obstet Gynaecol. 2021. PMID: 33624571
-
[The role of body weight and metabolic anomalies in ovulation induction].Contracept Fertil Sex. 1994 Mar;22(3):178-9. Contracept Fertil Sex. 1994. PMID: 8019608 French.
-
Low-dose gonadotropin induction of ovulation in anovulatory women: still needed in the age of IVF.Reproduction. 2018 Jul;156(1):F1-F10. doi: 10.1530/REP-17-0697. Epub 2018 Feb 19. Reproduction. 2018. PMID: 29459401 Review.
-
Ovulatory disorders in women with polycystic ovary syndrome.Clin Obstet Gynaecol. 1985 Sep;12(3):605-32. Clin Obstet Gynaecol. 1985. PMID: 3933879 Review.
Cited by
-
The impact of female obesity on the outcome of fertility treatment.J Hum Reprod Sci. 2010 May;3(2):62-7. doi: 10.4103/0974-1208.69332. J Hum Reprod Sci. 2010. PMID: 21209748 Free PMC article.
-
Clomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial.J Assist Reprod Genet. 2013 Nov;30(11):1477-85. doi: 10.1007/s10815-013-0090-2. Epub 2013 Sep 7. J Assist Reprod Genet. 2013. PMID: 24014214 Free PMC article. Clinical Trial.
-
Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan.Reprod Med Biol. 2013 Jul;12(3):71-77. doi: 10.1007/s12522-013-0145-1. Epub 2013 Apr 16. Reprod Med Biol. 2013. PMID: 23874146 Free PMC article.
-
Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.J Zhejiang Univ Sci B. 2005 Sep;6(9):897-902. doi: 10.1631/jzus.2005.B0897. J Zhejiang Univ Sci B. 2005. PMID: 16130192 Free PMC article.
-
Risk factors for missed abortion: retrospective analysis of a single institution's experience.Reprod Biol Endocrinol. 2022 Aug 9;20(1):115. doi: 10.1186/s12958-022-00987-2. Reprod Biol Endocrinol. 2022. PMID: 35945583 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical